SynthesisFrontiers in endocrinology2023

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer.

Xiangyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.